ShenZhen Consys Science & Technology Co., Ltd. (688788.SS)
CNY 33.8
(-1.26%)
CNY 33.8
(-1.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 236.29 Million | 233.3 Million | 610.29 Million | 654.92 Million | 674.37 Million | 551.38 Million |
| Cost of Revenue | 125.6 Million | 101.15 Million | 184.41 Million | 202.52 Million | 203.25 Million | 185.79 Million |
| Gross Profit | 110.68 Million | 132.14 Million | 425.88 Million | 452.4 Million | 471.12 Million | 365.58 Million |
| Operating Expenses | 337.2 Million | 268.11 Million | 255.36 Million | 253.51 Million | 173.2 Million | 91.97 Million |
| Selling, General and Administrative Expenses | 38.18 Million | 37.25 Million | 36.6 Million | 50.48 Million | 30.39 Million | 16.02 Million |
| Research and Development Expenses | 246.4 Million | 203.44 Million | 198.58 Million | 181.69 Million | 117.71 Million | 56.72 Million |
| Other Expenses | 65.22 Million | 27.4 Million | 20.18 Million | 21.33 Million | 25.09 Million | -47.24 Thousand |
| Cost and Expenses | 462.8 Million | 369.27 Million | 439.78 Million | 456.04 Million | 376.45 Million | 277.77 Million |
| Operating Income | -232.91 Million | -135.96 Million | 185.77 Million | 187.45 Million | 244.51 Million | 238.29 Million |
| Interest Expense | 2.66 Million | 877.55 Thousand | 1.18 Million | 8.86 Million | 8.03 Million | 1.28 Million |
| Income Tax Expense | -5.07 Million | -15.86 Million | 9.09 Million | 16.76 Million | 27.97 Million | 33.08 Million |
| Earnings before Tax | -226.6 Million | -211.81 Million | 185.47 Million | 192.47 Million | 244.43 Million | 238.24 Million |
| Net Income | -203.25 Million | -195.95 Million | 178.49 Million | 177.06 Million | 217.96 Million | 207.35 Million |
| Earnings Per Share Basic | -1.93 | -1.85 | 1.69 | 1.67 | 2.06 | 2.71 |
| Earnings Per Share Diluted | -1.93 | -1.85 | 1.69 | 1.67 | 2.06 | 2.71 |
| Weighted Average Shares Outstanding | 105.56 Million | 105.74 Million | 105.74 Million | 105.74 Million | 105.74 Million | 76.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 105.56 Million | 105.74 Million | 105.74 Million | 105.74 Million | 105.74 Million | 76.59 Million |
| Gross Margin | 0.47 | 0.57 | 0.70 | 0.69 | 0.70 | 0.66 |
| EBIT Margin | -0.68 | -0.29 | 0.38 | 0.34 | 0.45 | 0.50 |
| Profit Margin | -0.86 | -0.84 | 0.29 | 0.27 | 0.32 | 0.38 |
| EBITDA | -161.22 Million | -180.06 Million | 212.3 Million | 211.6 Million | 257.99 Million | 244.05 Million |
| Earnings Before Tax Margin | -0.99 | -0.58 | 0.30 | 0.29 | 0.36 | 0.43 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 77.29 Million | 95.32 Million | 14.29 Million | 79.8 Million | 236.29 Million | 59.27 Million |
| Cost of Revenue | 42.14 Million | 54.5 Million | 7.86 Million | 43.9 Million | 125.6 Million | 35.65 Million |
| Gross Profit | 35.14 Million | 40.82 Million | 6.42 Million | 35.89 Million | 110.68 Million | 23.62 Million |
| Operating Expenses | 78.23 Million | 139.34 Million | 84.4 Million | 118.51 Million | 469.2 Million | 89.51 Million |
| Selling, General and Administrative Expenses | 47.43 Million | 68.06 Million | 19.06 Million | -22.08 Million | - | 42.93 Million |
| Research and Development Expenses | 57.97 Million | 63.75 Million | 66.45 Million | 61.92 Million | - | 69.49 Million |
| Other Expenses | -27.17 Million | -7.52 Million | 469.57 | -118.51 Million | -469.2 Million | -13.48 Thousand |
| Cost and Expenses | 120.38 Million | 193.84 Million | 92.27 Million | 118.51 Million | 469.2 Million | 125.16 Million |
| Operating Income | -58.95 Million | -98.51 Million | -59.27 Million | -38.71 Million | -232.91 Million | -66.57 Million |
| Interest Expense | 112.5 Thousand | - | 1.34 Million | -889.91 Thousand | 1.21 Million | 803.34 Thousand |
| Income Tax Expense | -2.87 Million | -5.67 Million | -61.3 Thousand | 2.62 Million | -5.07 Million | -1.24 Million |
| Earnings before Tax | -58.93 Million | -96.24 Million | -59.27 Million | -38.63 Million | -232.85 Million | -66.58 Million |
| Net Income | -51.91 Million | -86.26 Million | -53.53 Million | -29.91 Million | -216.42 Million | -59.92 Million |
| Earnings Per Share Basic | -0.50 | -0.82 | -0.51 | -0.28 | - | -0.57 |
| Earnings Per Share Diluted | -0.50 | -0.82 | -0.51 | -0.28 | - | -0.57 |
| Weighted Average Shares Outstanding | 104.75 Million | 104.76 Million | 104.8 Million | 104.99 Million | 105.56 Million | 105.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.75 Million | 104.76 Million | 104.8 Million | 104.99 Million | 105.56 Million | 105.22 Million |
| Gross Margin | 0.45 | 0.43 | 0.45 | 0.45 | 0.47 | 0.40 |
| EBIT Margin | -0.76 | -0.92 | -5.33 | -0.52 | - | -0.97 |
| Profit Margin | -0.67 | -0.90 | -3.75 | -0.37 | -0.92 | -1.01 |
| EBITDA | -58.82 Million | -87.26 Million | -76.16 Million | -41.27 Million | - | -57.27 Million |
| Earnings Before Tax Margin | -0.76 | -1.03 | -4.15 | -0.49 | -0.99 | -1.12 |
MEDICAMEQ
3880
BHC
YIPS
STMEF
ALVAZ